Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1895 1
1896 1
1898 1
1900 1
1905 1
1908 1
1913 3
1916 1
1918 2
1922 2
1925 2
1932 4
1935 1
1940 1
1943 1
1946 5
1947 6
1948 3
1949 1
1950 1
1951 1
1952 3
1953 5
1957 1
1958 1
1959 1
1960 1
1961 1
1962 2
1964 1
1965 1
1966 4
1967 7
1968 8
1969 9
1970 14
1971 12
1972 7
1973 9
1974 11
1975 18
1976 19
1977 9
1978 14
1979 7
1980 5
1981 8
1982 7
1983 2
1984 3
1985 3
1986 6
1987 2
1988 2
1989 6
1990 10
1991 3
1992 4
1993 6
1994 4
1995 3
1996 3
1997 5
1998 4
1999 8
2000 13
2001 12
2002 12
2003 10
2004 24
2005 19
2006 27
2007 13
2008 12
2009 21
2010 21
2011 17
2012 28
2013 25
2014 22
2015 20
2016 22
2017 25
2018 25
2019 35
2020 41
2021 27
2022 31
2023 33
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

790 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Saad F, Clarke NW, Oya M, Shore N, Procopio G, Guedes JD, Arslan C, Mehra N, Parnis F, Brown E, Schlürmann F, Joung JY, Sugimoto M, Sartor O, Liu YZ, Poehlein C, Barker L, Del Rosario PM, Armstrong AJ. Saad F, et al. Among authors: barker l. Lancet Oncol. 2023 Oct;24(10):1094-1108. doi: 10.1016/S1470-2045(23)00382-0. Epub 2023 Sep 12. Lancet Oncol. 2023. PMID: 37714168
Reply.
Hofmeister MG, Edlin BR, Rosenberg ES, Rosenthal EM, Barker LK, Barranco MA, Hall EW, Mermin J, Ryerson AB. Hofmeister MG, et al. Among authors: barker lk. Hepatology. 2019 Aug;70(2):759-760. doi: 10.1002/hep.30635. Hepatology. 2019. PMID: 30945751 No abstract available.
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.
Penson RT, Valencia RV, Cibula D, Colombo N, Leath CA 3rd, Bidziński M, Kim JW, Nam JH, Madry R, Hernández C, Mora PAR, Ryu SY, Milenkova T, Lowe ES, Barker L, Scambia G. Penson RT, et al. Among authors: barker l. J Clin Oncol. 2020 Apr 10;38(11):1164-1174. doi: 10.1200/JCO.19.02745. Epub 2020 Feb 19. J Clin Oncol. 2020. PMID: 32073956 Free PMC article. Clinical Trial.
Attention and other constructs: evolution or revolution?
Koziol LF, Barker LA, Jansons L. Koziol LF, et al. Among authors: barker la. Appl Neuropsychol Child. 2015;4(2):123-31. doi: 10.1080/21622965.2015.1005482. Epub 2015 Feb 26. Appl Neuropsychol Child. 2015. PMID: 25719389 Review.
Sexual health of women with schizophrenia: A review.
Barker LC, Vigod SN. Barker LC, et al. Front Neuroendocrinol. 2020 Apr;57:100840. doi: 10.1016/j.yfrne.2020.100840. Epub 2020 Apr 13. Front Neuroendocrinol. 2020. PMID: 32298687 Review.
Preventive vaccines for tuberculosis.
Evans TG, Brennan MJ, Barker L, Thole J. Evans TG, et al. Among authors: barker l. Vaccine. 2013 Apr 18;31 Suppl 2:B223-6. doi: 10.1016/j.vaccine.2012.11.081. Vaccine. 2013. PMID: 23598486 Review.
790 results